Long-term effects of faecal microbiota transplantation
Long Term Safety and Efficacy of Faecal Microbiota Transplantation: a Nationwide Obeservational Study
This study looks at the long-term effects of stool transplants in adults who are getting the treatment for repeated Clostridium difficile infections or other health issues.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Joint Authority for Päijät-Häme Social and Health Care Academic / other |
| Locations | 1 site (Lahti) |
| Trial ID | NCT03732131 on ClinicalTrials.gov |
What this trial studies
This study aims to observe the long-term effects of faecal microbiota transplantation (FMT) in patients over 18 years old who are receiving FMT for recurrent Clostridium difficile infection or other medical conditions. Participants will provide written consent and will be monitored for outcomes and potential side effects through blood and fecal samples for one year, with follow-up questionnaires extending up to ten years post-transplant. The study is observational and does not involve any specific interventions.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who are undergoing faecal microbiota transplantation for recurrent Clostridium difficile infection or other medical conditions.
Not a fit: Patients who are under 18 years old or unable to provide written consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term safety and efficacy of faecal microbiota transplantation.
How similar studies have performed: Other studies have shown promising results regarding the efficacy of faecal microbiota transplantation, making this approach a relevant area of investigation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * \> 18 years age * receiving FMT for rCDI or any other madical condition * written consent * Not included in other FMT trials Exclusion Criteria: * Unable to provide written consent * \< 18 years age * Included in other FMT-trial
Where this trial is running
Lahti
- Joint Authority for Päijät-Häme Social and Health Care — Lahti, Finland (Recruiting)
Study contacts
- Study coordinator: Perttu Lahtinen, MD
- Email: perttu.lahtinen@phhyky.fi
- Phone: +358-3-819 11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.